洋地黄类药物治疗心衰再评价获益与风险并存.pptVIP

洋地黄类药物治疗心衰再评价获益与风险并存;心衰诊疗观念改变;洋地黄在心衰应用降低;应用逐年降低原因;洋地黄应用历史;全方面认识地高辛作用;药理作用;;;地高辛效应;神经体液效应;电生理效应; 其它效应;;地高辛临床试验结果;收缩性心衰地高辛应用;PROVED和RADIANCE中联合诊疗优势;Freedom from worsening HF in the digoxin withdrawn group and the digoxin group at 3 levels of SDC;The Effect of Digoxin on Mortality and Morbidity in Patients with Heart FailureThe Digitalis Investigation Group ;;DIG试验中地高辛和抚慰剂诊疗因心衰恶化死亡率和再住院率;DIG试验中地高辛在高危亚组2年随访;DIG试验中基线校正后2年死亡率和住院率;Kaplan–Meier plots for cumulative risk of all-cause death by SDC;Kaplan–Meier plots for cumulative risk of hospitalization due to worsening HF by SDC;Kaplan-Meier Plots f